B of A Securities Upgrades Haemonetics (HAE)
23/5 02:03
Fintel reports that on May 22, 2026, B of A Securities upgraded their outlook for Haemonetics (NYSE:HAE) from Neutral to Buy. Analyst Price Forecast Suggests 35.40% Upside...
|
|
|
23/5 02:03
Fintel reports that on May 22, 2026, B of A Securities upgraded their outlook for Haemonetics (NYSE:HAE) from Neutral to Buy. Analyst Price Forecast Suggests 35.40% Upside...